מיוזאק - Miozac
{{תר××¤× |×©× ××¢×ר×ת=×××××ק |×©× ××× ×××ת=Miozac |×©× ××× ××× ××=×××××ק - Miozac |×©× ××× ××× ×× ××× ×××תâ=Miozac |×¡× ××ר×××ת=×× ×××× ××¡× |ק×ש×ר ××××ר ××©×¨× ××ר×××ת1= ×××××ק ××××ר ××©×¨× ××ר×××ת |ת××× ×ª ×ר×××=https://mohpublic.z6.web.core.windows.net/IsraelDrugs/Rishum01_16_190413024.png |×ר××× ×¤×¢××=Â
- Dobutamine AS HYDROCHLORIDE 12.5 MG/ML {{×}C01CA07
|צ×רת ×ת×=ת××-×ר××× - I.V
|צ×רת ××× ××=תר××× ×××× ×ª ת×××¡× ×××× ×¤××××, CONCENTRATE FOR SOLUTION FOR INFUSION
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|×ספר ר×ש××=174 22 36662 99
|×©× ××¢× ×ר×ש××=RAZ PHARMACEUTICS LTD, ISRAEL
|×©× ×צר×=FISIOPHARMA S.R.L., ITALY
|×©× ××¦×¨× ×ק×צר=FISIOPHARMA
|ת×ר×× ××ש×=9/2020
|×ת××××=
Dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure.
|××× ×§×××ר××= |××רש×=×× |×¢××× ×ר×פ×=Â
|×¢××× ×צר××=Â
|×××ר×ת ××¢×××=Â
|ק×××¦× ×¤×¨×ק×××××ת (ATC)=
C01CA
Adrenergic and dopaminergic agents
|ר×ש××× ×ת×ר××=
|ש×××ק ××פסק=××
|ת×ר×× ×¢××××=16/07/2024
|×ת××ת ××× ××=
|×ת××××ת × ××=
|פר×ק×××× ××ק×=
|פר×ק×ק×× ××ק×=
|ש×××ש ××ר××× ××× ×§×=
|ת××××ת ××× ×ª×¨×פת××ת=
|ת×פע×ת ×××××=
|××פ×ש ××××ק×רפ×××=
}}
השינוי האחרון נעשה בֹ־16 ביולי 2024 ב־02:45